See Remarks · Caris Life Sciences, Inc. · Common Stock
Side
A
Value
—
Shares
64.0K
Price
—
Executed
Mar 6, 2026
Disclosed
Mar 10, 2026
Disclosure timeline4 days from execution to publication · legal deadline 2 business days
Mar 6 executedMar 10, 2026 disclosed
CAI · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+13 / 25
No reported dollar value · 51.8% of prior position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+4 / 15
1 prior trade recorded in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Denton John Russel filed this Form 4 reporting a grant or award of CAI on Mar 6, 2026. It became public on Mar 10, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
See Remarks
Denton John Russelcik:0002071923
Issuer
Caris Life Sciences, Inc.cik:0002019410
Revision history · 0
No field has changed since this record was first ingested.
